Citations

Showing 10 of 108152 citations.

Synovial fluid α defensin has comparable accuracy to synovial fluid white blood cell count and polymorphonuclear percentage for periprosthetic joint infection diagnosis
Ivy, Morgan I. , Sharma, Katyayini , Greenwood‐Quaintance, Kerryl E. , Tande, Aaron J. , Osmon, Douglas R. , Berbari, Elie F. , Mandrekar, Jay , Beauchamp, C.P., Hanssen, Arlen D. , Abdel, Matthew P. , Lewallen, David G. , Perry, Kevin I. , Block, Darci R , Snyder, Melissa R. , Patel, Robin , Mandrekar, Jayawant N. , Beauchamp, Christopher P., Perry, Kevin, Tande, Aaron , Patel, Robin , Abdel, Matthew P , Osmon, Douglas R , Greenwood-Quaintance, Kerryl

Mayo Clinic

The Bone & Joint Journal | June 1, 2021 | Volume: 103-B | Issue: 6 | Pages: 1119-1126

10.1302/0301-620x.103b6.bjj-2020-1741.r1 | PMID 34058872 Get It

Aims The aim of this study was to determine the diagnostic accuracy of α defensin (AD) lateral flow assay (LFA) and enzyme-linked immunosorbent assay (ELISA) tests for periprosthetic joint infection (PJI) in comparison to conventional synovial white blood cell (WBC) count and polymorphonuclear neutrophil percentage (PMN%) analysis. Methods Patients undergoing joint aspiration for evaluation of pain after total knee arthroplasty (TKA) or total hip arthroplasty (THA) were considered for inclusion. Synovial fluids from 99 patients (25 THA and 74 TKA) were analyzed by WBC count and PMN% analysis, AD LFA, and AD ELISA. WBC and PMN% cutoffs of ≥ 1,700 cells/mm3 and ≥ 65% for TKA and ≥ 3,000 cells/mm3 and ≥ 80% for THA were used, respectively. A panel of three physicians, all with expertise in orthopaedic infections and who were blinded to the results of AD tests, independently reviewed patient data to diagnose subjects as with or without PJI. Consensus PJI classification was used as the reference standard to evaluate test performances. Results were compared using McNemar’s test and area under the receiver operating characteristic curve (AUC) analysis. Results Expert consensus classified 18 arthroplasies as having failed due to PJI and 81 due to aseptic failure. Using these classifications, the calculated sensitivity and specificity of AD LFA was 83.3% (95% confidence interval (CI) 58.6 to 96.4) and 93.8% (95% CI 86.2 to 98.0), respectively. Sensitivity and specificity of AD ELISA was 83.3% (95% CI 58.6 to 96.4) and 96.3% (95% CI 89.6 to 99.2), respectively. There was no statistically significant difference between sensitivity (p = 1.000) or specificity (p = 0.157) of the two AD assays. AUC for AD LFA was 0.891. In comparison, AUC for synovial WBC count, PMN%, and the combination of the two values was 0.821 (sensitivity p = 1.000, specificity p < 0.001), 0.886 (sensitivity p = 0.317, specificity p = 0.011), and 0.926 (sensitivity p = 0.317, specificity p = 0.317), respectively. Conclusion The diagnostic accuracy of synovial AD for PJI diagnosis is comparable and not statistically superior to that of synovial WBC count plus PMN% combined. Cite this article: Bone Joint J 2021;103-B(6):1119–1126.
Natural History of Patients With Ischemia and No Obstructive Coronary Artery Disease
Reynolds, Harmony R. , Picard, Michael H. , Spertus, John A. , Peteiro, Jesús , López‐Sendón, José , Senior, Roxy , El‐Hajjar, Mohammad , Čelutkienė, Jelena , Shapiro, Michael D. , Pellikka, Patricia A. , Kunichoff, Dennis , Anthopolos, Rebecca , Abdul-Nour, Khaled, Khouri, Michel G. , Берштейн, Л. Л. , Beltrame, John F. , Min, James K. , Fleg, Jerome L. , Li, Yi , Hochman, Judith S. , Lopez Sendon, Jose Luis , Bershtein, Leonid , Beltrame, John F , Hochman, Judith S , Pellikka, Patricia A , Peteiro, Jesus , Spertus, John A , Shapiro, Michael D , Celutkiene, Jelena , Reynolds, Harmony R , Alfakih, Khaled , Belder, Mark de , Poh, Kian Keong , Maron, David J.

Mayo Clinic

Circulation | June 1, 2021 | Volume: 144 | Issue: 13 | Pages: 1008-1023

10.1161/circulationaha.120.046791 | PMID 34058845 Get It

Background: Ischemia with no obstructive coronary artery disease (INOCA) is common and has an adverse prognosis. We set out to describe the natural history of symptoms and ischemia in INOCA. Methods: CIAO-ISCHEMIA (Changes in Ischemia and Angina over One Year in ISCHEMIA Trial Screen Failures With INOCA) was an international cohort study conducted from 2014 to 2019 involving angina assessments (Seattle Angina Questionnaire) and stress echocardiograms 1 year apart. This was an ancillary study that included patients with a history of angina who were not randomly assigned in the ISCHEMIA trial. Stress-induced wall motion abnormalities were determined by an echocardiographic core laboratory blinded to symptoms, coronary artery disease status, and test timing. Medical therapy was at the discretion of treating physicians. The primary outcome was the correlation between the changes in the Seattle Angina Questionnaire angina frequency score and changes in echocardiographic ischemia. We also analyzed predictors of 1-year changes in both angina and ischemia, and we compared CIAO participants with ISCHEMIA participants with obstructive coronary artery disease who had stress echocardiography before enrollment, as CIAO participants did. Results: INOCA participants in CIAO were more often female (66% of 208 versus 26% of 865 ISCHEMIA participants with obstructive coronary artery disease, P <0.001), but the magnitude of ischemia was similar (median 4 ischemic segments [interquartile range, 3–5] both groups). Ischemia and angina were not significantly correlated at enrollment in CIAO ( P =0.46) or ISCHEMIA stress echocardiography participants ( P =0.35). At 1 year, the stress echocardiogram was normal in half of CIAO participants, and 23% had moderate or severe ischemia (≥3 ischemic segments). Angina improved in 43% and worsened in 14%. Change in ischemia over 1 year was not significantly correlated with change in angina (ρ=0.029). Conclusions: Improvement in ischemia and angina were common in INOCA but not correlated. Our INOCA cohort had a degree of inducible wall motion abnormalities similar to concurrently enrolled ISCHEMIA participants with obstructive coronary artery disease. Our results highlight the complex nature of INOCA pathophysiology and the multifactorial nature of angina. Registration: URL: https://www.clinicaltrials.gov . Unique identifier: NCT02347215.
Using MR elastography to assess portal hypertension and response to beta‐blockers in patients with cirrhosis
Danielsen, Karen Vagner , Hove, Jens Dahlgaard , Nabilou, Puria , Yin, Meng , Zhao, Mirabella , Teisner, Ane, Møller, Søren , Yin, Meng , Chen, Jun , Kallemose, Thomas , Siebner, Hartwig Roman , Ehman, Richard L. , Bendtsen, Flemming

Mayo Clinic

Liver International | June 1, 2021 | Volume: 41 | Issue: 9 | Pages: 2149-2158

10.1111/liv.14981 | PMID 34060714 Get It

Abstract Background MR elastography can determine organ‐related stiffness, which reflects the degree of fibrosis. Liver stiffness increases in cirrhosis, and stiffness increases further post‐prandially due to increased portal blood in‐flow. Non‐selective beta‐blockers (NSBB) reduce the portal venous inflow, but their effect on liver and spleen stiffness are disputed. Aims To assess whether MR elastography of the liver or spleen reflects the severity of cirrhosis, whether treatment with NSBB changes liver and spleen stiffness and whether changes in stiffness can predict the effect of NSBB on portal pressure. Methods Fifty‐two patients with cirrhosis underwent liver vein catheterization and two‐dimensional (2D) MR elastography on separate days. Thirty‐six of the patients had a hepatic venous pressure gradient (HVPG) of ≥12 mmHg and were tested prior to, and after, intravenous infusion of NSBB using HVPG measurement and MR elastography. Results HVPG showed a strong, positive, linear relationship with liver stiffness ( r 2 = 0.92; P < .001) and spleen stiffness ( r 2 = 0.94; P < .001). The cut‐off points for identifying patients with a HVPG ≥ 12 mmHg were 7.7 kPa for liver stiffness (sensitivity 0.78, specificity 0.64) and 10.5 kPa for spleen stiffness (sensitivity 0.8, specificity 0.79). Intravenous administration of NSBB significantly decreased spleen stiffness by 6.9% (CI: 3.5‐10.4, P < .001), but NSBB had no consistent effect on liver stiffness. However, changes in spleen stiffness were not related to the HVPG response ( P = .75). Conclusions Two‐dimensional MR elastographic estimation of liver or spleen stiffness reflects the degree of portal hypertension in patients with liver cirrhosis, but changes in stiffness after NSBB do not predict the effect on HVPG.
Modulation of Transforming Growth Factor Type β Action by Activated Ras and c-myc
Leof, Edward B. , Proper, Jacqueline A., Moses, Harold L.

Mayo Clinic

Molecular and Cellular Biology | June 1, 2021 | Volume: 7 | Issue: 7 | Pages: 2649-2652

10.1128/mcb.7.7.2649-2652.1987 | PMID 3475570 Get It

Introduction. Biologics in spine surgery
Levi, Allan D. , Shaffrey, Christopher I. , Haid, Regis W., Boden, Scott D. , Clarke, Michelle J. , Mazur, Marcus D.

Mayo Clinic

Neurosurgical Focus | June 1, 2021 | Volume: 50 | Issue: 6 | Pages: E1

10.3171/2021.3.focus21171 | PMID 34062503 Get It

Exploring the Role of Antinuclear Antibody Positivity in the Diagnosis, Treatment, and Health Outcomes of Patients With Rheumatoid Arthritis
Paknikar, Sujaytha S. , Crowson, Cynthia S. , Davis, John M. , Thanarajasingam, Uma , Davis, John M

Mayo Clinic

ACR Open Rheumatology | June 1, 2021 | Volume: 3 | Issue: 6 | Pages: 422-426

10.1002/acr2.11271 | PMID 34060254 Get It

ObjectiveThe objective of this study was to describe differences in the clinical course of patients with rheumatoid arthritis (RA) who are antinuclear antibody (ANA)–positive compared with those who are ANA‐negative.MethodsThis was a retrospective population‐based cohort study of residents in Olmsted County, Minnesota, who first fulfilled 1987 American College of Rheumatology criteria for RA in 2009‐2014. Data were collected on first documentation of joint swelling. Data on rheumatoid factor or anti‐cyclic citrullinated peptide antibody testing and the ANA level were also collected. Comparisons between groups were performed by using χ2 and rank sum tests.ResultsIn this cohort, 64% of patients were tested for ANA within ±90 days of RA criteria fulfillment. In the161 patients with ANA testing, 25% were ANA‐positive. Patients who were ANA‐positive were younger, female, and less likely to be current smokers. ANA positivity did not differ between patients with RA who were seropositive and seronegative. In seropositive patients who were ANA‐positive, there was an increased time to fulfillment of RA criteria, increased time to treatment with disease‐modifying antirheumatic drugs (DMARDs), and increased likelihood of being treated with hydroxychloroquine as opposed to methotrexate. Other outcomes, including disease activity and mortality, did not differ significantly between groups.ConclusionIn patients with RA, important differences exist between those who are ANA‐positive and ANA‐negative in terms of time to fulfillment of RA criteria and time to DMARD initiation as well as choice of initial pharmacotherapy. These findings could indicate a difference in clinical presentation or perception of patients with RA who are ANA‐positive. Further research is needed to study the long‐term outcomes of patients with RA who are ANA‐positive.
Orbital anatomy magnetic resonance imaging in diplopic versus non-diplopic patients after glaucoma drainage device placement
Shah, Saumya M. , Kilgore, Khin P. , Bothun, Erick D. , Khanna, Cheryl L. , Khanna, Cheryl L , Hunt, Christopher H.

Mayo Clinic

European Journal of Ophthalmology | June 1, 2021 | Volume: 32 | Issue: 1 | Pages: 341-346

10.1177/11206721211020206 | PMID 34058906 Get It

Purpose: New-onset persistent diplopia has become a common complication after glaucoma drainage device (GDD) placement. Understanding the orbital anatomy of such patients may provide information regarding risk of diplopia, GDD selection, and post-operative management. The purpose of this study was to examine the orbital anatomic differences in diplopic and non-diplopic patients after GDD implantation using high-resolution MRI. Methods: Seven eyes ( N = 4 with diplopia and N = 3 without diplopia after GDD placement) of seven patients that had undergone placement of Baerveldt 250 (B250), Baerveldt 350 (B350), or Ahmed FP7 (FP7) GDD were prospectively enrolled at a single institution. All patients underwent a 3.0T orbital MRI with 3D volumetric T1 and T2 weighted sequence. Images were analyzed for orbital volume, axial length, orbital distances, presence of superior rectus-lateral rectus (SR-LR) band, position of GDD, and SR-LR angles. Results: Patients with diplopia had smaller mean ± SD orbital axial (911.5 ± 111.8 mm 3 vs 931.7 ± 79.7 mm 3 ) and coronal volumes (1162.5 ± 145.5 mm 3 vs 1180 ± 34.6 mm 3 ) compared to non-diplopic patients. Average orbital rim distances were larger for the diplopic group. The SR-LR displacement angle for diplopic patients was larger (101.6° ± 8.1 vs 94.7° ± 17.6) while the SR-LR quadrantic angle (86.6° ± 4.2 vs 89.1° ± 4.3) was smaller. SR-LR band was present and intact in all patients. GDD malpositioning was not evident in any patient. Conclusion: The decreased orbital axial and coronal volumes as well as increased orbital rim distances in diplopic patients suggests the need for further studies to understand the role of orbital anatomy in occurrence of diplopia. Dynamic MRI imaging may be helpful in identifying differences in extraocular muscle function that reveal an etiology of diplopia in patients with GDD implantation.
Cognitive Heterogeneity in Alzheimer Clinical Trials
Buckley, Rachel F. , Buckley, Rachel F , Knopman, David S.

Mayo Clinic

Neurology | June 1, 2021 | Volume: 96 | Issue: 22 | Pages: 1017-1018

10.1212/wnl.0000000000012027 | PMID 34550902 Get It

Cerebrovascular Complications of Vestibular Schwannoma Surgery
Rayan, Tarek, Helal, Ahmed , Graffeo, Christopher S. , Perry, Avital , Driscoll, Colin L. W., Link, Michael J. , Carlstrom, Lucas P.

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | May 31, 2021 | Volume: 83 | Issue: S 02 | Pages: e443-e448

10.1055/s-0041-1730895 | PMID 35832937 Get It

Abstract Objective Cerebrovascular complications (CVC) are rare consequences of vestibular schwannoma (VS) surgery. Our objective was to assess incidences of findings suggestive of postoperative CVC in a large single surgeon cohort, as well as potential risk factors, and implications. Study Design A cohort of 591 patients was retrospectively reviewed. Postoperative magnetic resonance images were screened for findings suggestive of stroke, T2 hyperintensity in the cerebellopontine angle structures or new encephalomalacia. Clinical records were queried for findings consistent with postoperative CVC. Results In total, 61 patients had radiographic findings consistent with possible postoperative CVC (10%); of them, eight had documented intraoperative vascular injury (1.4%), and four had postoperative clinical exam changes indicative of CVC (0.7%). Clinically manifest intraoperative vascular injuries occurred in four patients and involved the petrosal venous complex (n = 3, 5%) or anterior inferior cerebellar artery (n = 1, 2%); clinical deficits included hemiparesis (n = 1, 2%), facial anesthesia (n = 2, 4%), dysphagia (n = 2, 2%), and unfavorable facial nerve function in two (50%). Three out of four patients in this group required out-of-home placement (75%). Clinical CVCs (n = 4) were not significantly associated with tumor size, tumor cyst, gross total resection, or length of stay. Patients with clinical CVC were significantly more likely to require posthospitalization rehabilitation (19 vs. 75%, p = 0.02; 14 vs. 100%, p = 0.0002). Conclusion Although radiographic findings suggestive of CVC were unexpectedly common in this cohort, intraoperative vascular injury and postoperative clinical CVC were exceedingly rare. The association between unfavorable facial nerve outcome and clinical CVC is likely a marker for more difficult operations, predisposing to higher risk of complications.